COVID-19 rapid test ImmTek™

for antigensSARS-COV-2nasopharyngeal

ImmTekTM COVID-19 Antigen Rapid Test is a single use in vitro immunochromatographic assay intended for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasopharyngeal swab specimens from individuals with suspected symptoms within 5 days, as an aid to the initial diagnosis of SARS-CoV-2 infection. Test results should be interpreted by medical professionals in conjunction with clinical history and symptoms. Specification Test Principle: Lateral Flow Immunochromatographic Assay Target Antigen: SARS-CoV-2 Nucleocapsid Protein Interpretation: Clear and accurate reading of dual colored C line and T line Limit of Detection: 3.13x102 TCID50 /ml Cross Reactivity: No cross reactivity with other viruses and bacteria tested. Interference: Not affected by the interfering substances tested. Storage: Room Temperature 15-30°C (59-86°F) Order Information Package 20 Tests/Box Package 25 Tests/Box